1 recruiting, 1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Andreas Josefsson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Implementation of Precision Medicine in High-risk Prostate Cancer High-risk treatment SOC, Active monitoring, Radical prostatectomy - Prostate Cancer | Recruiting | Andreas Josefsson | 5500 | 2024-06-10 | 2025-09-03 | |
| Enzalutamide Treatment in COVID-19 Enzalutamide Pill - COVID-19, Corona Virus Infection | Phase 2 | Terminated | Andreas Josefsson | 42 | 2020-07-15 | 2022-06-02 |
COVID-19 (1) · Coronavirus Infections (1) · Prostatic Neoplasms (1)
Androgen Antagonists (1) · Radiotherapy (1) · enzalutamide (1)
Sweden (2)